Aclarion Inc Cash Flow Conversion Efficiency
Aclarion Inc cash flow conversion efficiency. Based on the latest financial reports, Aclarion Inc (ACON) has a cash flow conversion efficiency ratio of -0.093x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.16 Million) by net assets ($12.50 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Aclarion Inc for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Aclarion Inc (2019–2024)
Cash flow conversion efficiency of Aclarion Inc from 2019 to 2024. This chart illustrates how Aclarion Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ACON live share price for real-time trading data and today's change.
Aclarion Inc Cash Flow Conversion Ratio Explained
Aclarion Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Aclarion Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aclarion Inc ranked by their cash flow conversion efficiency. Review financial flexibility index of Aclarion Inc to assess the company's free cash flow relative to its total liabilities.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Starbox Group Holdings Ltd. Ordinary Shares
NASDAQ:STBX
|
-0.001x |
|
Clean Motion AB
ST:CLEMO
|
-0.193x |
|
Borders & Southern Petroleum plc
LSE:BOR
|
0.000x |
|
DCM Financial Services Limited
NSE:DCMFINSERV
|
0.000x |
|
BEACN Wizardry & Magic Inc
V:BECN
|
0.886x |
|
2cureX AB
ST:2CUREX
|
3.288x |
|
Superior Mining International Corp
V:SUI
|
0.011x |
|
Ambipar Emergency Response
NYSE:AMBIQ
|
0.074x |
Annual Cash Flow Conversion Efficiency for Aclarion Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Aclarion Inc from 2019 to 2024. Also see Aclarion Inc assets under control for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $970.06K | $-5.27 Million | -5.434x | -208.48% |
| 2023-12-31 | $-728.00K | $-3.65 Million | 5.010x | +309.84% |
| 2022-12-31 | $2.23 Million | $-5.31 Million | -2.387x | -682.05% |
| 2021-12-31 | $-5.73 Million | $-2.35 Million | 0.410x | +61.97% |
| 2020-12-31 | $-7.08 Million | $-1.79 Million | 0.253x | -89.67% |
| 2019-12-31 | $-1.70 Million | $-4.17 Million | 2.451x | -- |
About Aclarion Inc
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom softwa… Read more